Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.

about

CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort

P2860

Q58698638-24D7348D-477E-4076-A94D-65BDC6854AB1

P2860

Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.

Item

http://www.wikidata.org/entity/Q38851461

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pharmacokinetic and pharmacody ...... nt of chronic lower back pain.

@en

type

Item

label

Pharmacokinetic and pharmacody ...... nt of chronic lower back pain.

@en

prefLabel

Pharmacokinetic and pharmacody ...... nt of chronic lower back pain.

@en

P1476

Pharmacokinetic and pharmacody ...... nt of chronic lower back pain.

@en

P2093

Mellar P Davis

http://www.w3.org/2001/XMLSchema#string

P2860

Opioids for low back pain

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes

Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids

A novel tool for the assessment of pain: validation in low back pain

Abuse potential of intravenous oxycodone/naloxone solution in nondependent recreational drug users.

Opioid formulations with sequestered naltrexone: a perspective review.

Pain sensitivity subgroups in individuals with spine pain: potential relevance to short-term clinical outcome.

Association between a composite score of pain sensitivity and clinical parameters in low-back pain.

Differences in brain structure and function in older adults with self-reported disabling and nondisabling chronic low back pain

An updated overview of clinical guidelines for the management of non-specific low back pain in primary care.

P304

823-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425255.2016.1191469

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27253690

http://www.w3.org/2001/XMLSchema#string

P921

Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.

about

P2860

P2860

Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921